Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan for fat accumulation in HIV
NCT01088295Phase 2Completed
- Sponsor
- University of California, Los Angeles
- Start
- May 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of telmisartan in HIV-associated lipodystrophy (HALS), sponsored by University of California, Los Angeles. Primary endpoint: Median Change in Visceral Adipose Tissue Volume at 24 weeks. Started May 2010; status: completed.
02
Drugs
telmisartan
03
Conditions
HIV-associated lipodystrophy (HALS)
Beyond the preview
Go deeper on NCT01088295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01088295.